The Systemic Flaw in Clinical Trials
Clinical trials not reporting — or even determining — the racial and ethnic composition of participants are a disservice to both clinicians and patients.
Related Articles
AHA Conference Recap: Key Insights for Thromboembolic Disease Prevention
Join us for a live symposium on antithrombotic therapy where leaders in the field will exchange ideas on the latest advances in thromboembolic disease manage…
The Value of New Fluid Management Technologies for Heart Failure
Heart failure is associated with a very high hospital readmission rate, which is burdensome and costly for patients, hospitals, and healthcare systems. Earli…
Elevating Image-Guided Risk Assessment for Proactive CV Prevention
Despite major advances in the improvement of outcomes related to atherosclerotic cardiovascular disease over the last few decades, itremains the leading caus…
AHA Conference Recap: Key Insights for Thromboembolic Disease Prevention
Join us for a live symposium on antithrombotic therapy where leaders in the field will exchange ideas on the latest advances in thromboembolic disease manage…
Hot Off the PH Press: Real-World Insights Into CTEPH Care
Join us for a 15-minute live social media event with leading experts Nick Kim, MD and Marc Humbert, MD to learn about the burden of…
AHA Conference Recap: Key Insights for Thromboembolic Disease Prevention
Join us for a live symposium on antithrombotic therapy where leaders in the field will exchange ideas on the latest advances in thromboembolic disease manage…
Hot Off the PH Press: Real-World Insights Into CTEPH Care
Join us for a 15-minute live social media event with leading experts Nick Kim, MD and Marc Humbert, MD to learn about the burden of…
Exploring New Paradigms in Thrombosis
Anticoagulant use has been critical in thrombosis management; however, currently available agents are often underprescribed, underdosed, and associated with …
Exploring New Paradigms in Thrombosis
Anticoagulant use has been critical in thrombosis management; however, currently available agents are often underprescribed, underdosed, and associated with …
Exploring New Paradigms in Thrombosis
Anticoagulant use has been critical in thrombosis management; however, currently available agents are often underprescribed, underdosed, and associated with …